Does combination therapy work in chronic thromboembolic pulmonary hypertension?

OBJECTIVE: The current experience with combination therapy in chronic thromboembolic pulmonary hypertension (CTEPH) is limited. We present the first survival results up to 5 years for dual combination therapy versus monotherapy in CTEPH. METHODS: All consecutive, non-operated CTEPH or residual PH af...

Descripción completa

Detalles Bibliográficos
Autores principales: van Thor, M.C.J., Snijder, R.J., Kelder, J.C., Mager, J.J., Post, M.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270605/
https://www.ncbi.nlm.nih.gov/pubmed/32518816
http://dx.doi.org/10.1016/j.ijcha.2020.100544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270605/
https://www.ncbi.nlm.nih.gov/pubmed/32518816
http://dx.doi.org/10.1016/j.ijcha.2020.100544

Ejemplares similares